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Cardiovascular diseases and metabolic complications caused by hyperlipidemia are the leading cause of death
globally. In this study, the hypolipidemic potency of Sesamum indicum (SI) seeds was investigated. Of the thirtyfive (35) male rats used in the study, five (5) were randomly selected for baseline measurements and thirty (30)
were fed high fat diet (HFD) for four (4) weeks before random assignment into three (3) groups. The experi
mental group was treated with 50% SI seed, the positive control group was given a hypolipidemic drug, ator
vastatin (5 mg/kg/day) while the untreated group served as the negative control. With SI administration, the
dyslipidemia induced by the HFD consumption in the plasma and the investigated body organs was reversed to a
comparable degree with that of atorvastatin treatment. Taken together, this study demonstrates the hypolipi
demic potency of SI in ameliorating hyperlipidemia and its associated complications, facilitated by the inhibition
of HMG-CoA reductase activity.

1. Introduction
Hyperlipidemia is the major cause of cardiovascular diseases (CVDs)
and co-morbidities, and account for major mortality around the world,
as it involves abnormal levels of circulating plasma lipids (Shimada
et al., 2004). High concentrations of serum cholesterol, especially LDLcholesterol, have been implicated as a high-risk factor for cardiovascu
lar diseases as the deposition of oxidized low density lipoproproteins
(LDL) leads to plaque formation and thickening of the arteries, resulting
in cardiovascular complications (Reena et al., 2011; Shimada et al.,
2004). Serum cholesterol concentration requires rigorous control.
Recently, reports correlating improvement in cardiovascular health with
the administration of botanical dietary supplements have been on a
continual increase (Hsu & Parthasarathy, 2017; Mahmood et al., 2010;

Nwozo et al., 2017; Visavadiya & Narasimhacharya, 2011).
Dietary intervention is recognized as a key measure in patient ther
apy and in the maintenance of human health. Diets rich in antioxidants
have been shown to play an essential role in the prevention of cardio
vascular disease and cancer and compare favorably with drug treat
ments for hyperlipidemia and hypertension (Hsu & Parthasarathy, 2017;
Kris-Etherton et al., 2002; Mahmood et al., 2010; Nwozo et al., 2017).
Dietary fat is deemed to play an important role in modulating risk fac
tors for cardiovascular diseases (Hunter et al., 2010). As reported pre
viously, replacing saturated fat with polyunsaturated fat has been found
to obviate coronary events in animals and humans (Hegsted et al., 1993;
Oyinloye et al., 2016; Sirato-Yasumoto et al., 2001). However, excessive
consumption of unsaturated fatty acids leads to higher peroxidation in
lipoproteins (Hegsted et al., 1993).

Abbreviations: AMPK, adenosine monophosphate-activated protein kinase; CD36, cluster of differentiation 36; CPT1, carnitinepalmitoyltransferase-1; CVD,
cardiovascular disease; HDL, high density lipoprotein; HDL-C, high-density lipoprotein-cholesterol; HDL-PL, high-density lipoprotein-phospholipid; HDL-TG, highdensity lipoprotein-triglyceride; HFD, high fat diet; HMG-CoA, 3-Hydroxy-3-methyl glutaryl-coenzyme A; LDL, low density lipoprotein; NCD, non-communicable
disease; PPAR-α, peroxisome proliferator-activated receptor-α; SI, Sesamum indicum; SREBP1, sterol regulatory element binding protein-1; TC, total cholesterol;
UCP2, uncoupling protein 2; VLDL, very low-density lipoprotein.
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Sesame seeds (Sesamum indicum) a member of the Pedaliaceae family
is regarded as the oldest oil-yielding seed crop known to humanity. The
oil seed is cultivated and obtained in high yields across the tropical and
subtropical regions of Africa (Nigeria, Ethiopia, Burkina Faso, Somalia,
Tanzania and Uganda), Asia (China, India, Myanmar, Korea, Russia and
Turkey) and America (Mexico and South America) (Nzikou et al., 2009)
due to its wide spectrum of pharmacological activities, therapeutic and
nutritional importance which includes cholesterol-lowering effect and
prevention of high blood pressure, attributable to the presence of two
unique substances in the seed: sesamin and sesamolin (Aslam et al.,
2020). In many parts of the world, sesame seed has been utilized in the
cure/prevention of various illnesses due to its high level of mono- and
polyunsaturated fatty acids (omega-3 and omega-6 fatty acids), vitamin
E, phytosterols, fiber, and other nutraceutical components (Andargie
et al., 2021; Asgary et al., 2013; Kumar et al., 2013). The lignan con
stituents have attracted significant attention due to their antiaging,
anticancer, antidiabetic, anti-inflammatory and antioxidative properties
(Afroz et al., 2019; Hsu & Parthasarathy, 2017; Kumar & Singh, 2015;
Nwozo et al., 2017; Wu et al., 2019). Although a large body of research
had been directed towards unravelling the nutritional and therapeutic
relevance of Sesamum indicum (SI) oils, however, less attention is focused
on the health-promoting effects of the seeds, hence the main thrust of the
present study.
3-Hydroxy-3-methyl glutaryl-CoA reductase or HMG-CoA reductase
(EC 2.3.3.10) is a polytopic transmembrane protein and a rate-limiting
enzyme in cholesterol biosynthesis catalyzing the reaction mediated
by sterols and non-sterol metabolites derived from mevalonate, in which
HMG-CoA is converted to mevalonate (Mukherjee et al., 2016). HMGCoA reductase inhibitory activity has been the focus of numerous and
extensive research to discover novel anticholesterolemic drugs based on
cholesterol-synthesis-inhibiting mechanism. Among them, statins of
synthetic origin have been shown to display hypolipidemic effect via a
competitive inhibitory effect on HMG-CoA reductase via the mevalonate
pathway. Though statins are well tolerated, they are sometimes reported
to have side effects leading to muscle tissue wastage, renal failure and
hepatotoxicity (Babu & Li, 2015; Bjornsson, 2017). It is therefore
imperative to investigate alternative diet therapy with lipid-lowering
effect with minimal or no side-effects, possibly to make way for alter
nate means of managing hyperlipidemia and its associated
co-morbidities. In this regard, in the present study, we hypothesized that
Sesamum indicum (SI) seeds could serve as an effective nutraceutical to
ameliorate hyperlipidemia-associated morbidities with minimal
side-effects as commonly encountered with the use of standard hypo
lipidemic drugs. Thus, we compared the effect of SI with the use of oral
hypolipidemic drug ‘atorvastatin’ in managing hyperlipidemia in model
Wistar strain rats and established its hypolipidemic potency in treating
hyperlipidemia and associated complications.

room temperature of 27 ± 3 ◦ C, 12 h light and dark cycle, acclimatized
for 2 weeks and fed ad libitum. The cages, water and feeding troughs as
well as the animal house were cleaned on daily basis and maintained in
good sanitary condition to enhance the well-being of the animals. The
animals were weighed fortnightly and all experiments including animal
handling were carried out using standard protocols in accordance with
the guidelines of the Institutional Animal Care and Use Committee as
approved by the Ethical Committee of Olabisi Onabanjo University, AgoIwoye, Ogun State, Nigeria.
Following the rats’ acclimatization for two (2) weeks and mainte
nance on commercial rat chow and portable drinking water, five (5) rats
were randomly selected for baseline measurement while the remaining
thirty (30) rats were fed high-fat diet for four weeks. The composition of
the commercial rat chow and high-fat diet are presented on Table 1. The
animals were thereafter randomly assigned into three (3) groups
namely: the experimental group (treated with 50% SI seed + 50% HFD),
the positive control (treated orally with 5 mg/kg/day atorvastatin +
HFD) and the negative control (untreated and maintained on HFD)
groups. Each group was treated for four (4) weeks. Five (5) animals were
randomly selected and sacrificed from each group fortnightly with the
kidney, liver, heart and brain excised to investigate the lipid profile. The
HMG-CoA reductase activity in the rats’ plasma was also investigated in
all the groups. None of the experimental animals was excluded during
the whole experimental process.
2.3. Lipid extraction from rat organs and plasma
10% homogenate of each tissue was prepared in chlor
oform–methanol mixture (2:1, v/v) in an ice-cold environment and
centrifuged at 4,000 rpm for 10 min. Lipids were extracted afterwards
from the homogenate using the method of Folch et al. (1957), following
the scheme reported by Banjoko et al. (2012).
2.4. Lipid profile determination
Total cholesterol and triglyceride concentrations of the plasma and
extracted lipids from the rat organ homogenates were determined with
commercial assay kits (Randox Laboratories, Antrim, United Kingdom).
High density lipoprotein (HDL)-cholesterol and triglycerides content
were determined with the same commercial kits used for total choles
terol and triglyceride concentration estimations after very low-density
lipoproteins (VLDL) were precipitated with heparin-MnCl2 solution as
described by Gidez et al. (1982).
2.5. Determination of total phospholipids content in rat organs and
plasma
Total phospholipids content in the organs were extracted with
chloroform–methanol mixture (2:1 v/v) as described by Folch et al.
(1957) after which phospholipids content was determined following the

2. Materials and methods
2.1. Materials

Table 1
Composition of high fat diet and commercial rat chow used in the study.

All the chemicals used in the study were of analytical grade. Glassdistilled water was used for all preparations. SI seeds, maize and palm
oil were purchased from a local market at Sabo, Sagamu, Ogun State,
Nigeria. The SI seeds were cleaned of stones, sand and other particles,
washed, sun-dried and ground to fine powder. Groundnut cake was
obtained from Enigbokan Mill, Ikenne-Remo, Ogun State, Nigeria while
commercial rat chow was purchased from Ladokun Feeds, Mokola,
Ibadan, Oyo State, Nigeria.
2.2. Animal management
Thirty-five (35) four-week old male Wistar rats were obtained from
the Department of Physiology, University of Ibadan, Ibadan, Nigeria and
housed in well-ventilated and spacious single cell cage at a controlled
2

Composition of high fat diet

Proximate composition of high fat diet and
commercial rat chow

Ingredient

g/
kg

Component

High fat
diet (%)

Commercial rat
chow (%)

Maize
Full-cream
powdered milk
Groundnut cake
Palm oil
Vitamin mix
Mineral mix
Methionine
Cholesterol

500
300

Carbohydrate
Protein

51.6
19.4

68.4
21.0

200
50
20
20
3
10

Fat
Vitamins
Minerals
Methionine
Cholesterol
Fibre

16.1
2.72
2.72
0.28
0.91
5.5

3.5
2.0
2.0
–
–
6.0
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method of Stewart (1980).

3.2. Ameliorative effect of Sesamum indicum administration on the lipid
profile of hyperlipidemic rats

2.6. HMG-CoA reductase activity assay in the plasma

The estimated total cholesterol (TC) concentration in both the he
patic and extra-hepatic tissues as well as the plasma of the animals
studied is depicted in Fig. 1a. It is noteworthy that the TC concentration
was significantly lower in the SI-treated rats across all the investigated
tissues in the study, with the anti-hypercholesterolemic effect of SI being
more pronounced in the liver followed by the heart, and then the kidney,
brain and plasma, as there was about 3-fold reduction in the cholesterol
concentration compared with that of the untreated rats. As inferred from
the study outcomes, the consumption of the hyperlipidemic diet resulted
in hypercholesterogenesis as there was 10-, 8- and 6-fold respective
increments in cholesterol concentrations in the liver, heart, kidney,
brain and plasma of the untreated rats compared with the baseline data.
However, the continued administration of SI reversed the cholestero
genesis to similar levels observed with atorvastatin treatment. These
observations are consistent with that of El-Baz et al. (2015) who re
ported 196.3 and 206.15% lipid reduction in hypercholesterolemic rat
models by administration of 5 and 10% prophylactic black sesame seed
oil. This observation is implicative of the hypolipidemic potency of SI
and its comparative effectiveness with the use of the lipid-scavenging
drug, atorvastatin.
From the data presented in Fig. 1b, the triglyceride (TG) constipation
in the untreated rats induced by the consumption of the hyperlipidemic
diet was reversed in the SI-treated rats in a comparable degree to that of
the drug-treated rats across all tissues investigated in the study. The
significant reduction in the TG concentration was more evident in all the
studied organs compared with the plasma as there was about 8-fold
reduction in the brain and 5-fold reduction in the liver, heart and kid
ney compared with only about 2-fold reduction in the plasma. The
observed outcomes are consistent with the reduced levels of TC, TG and
LDL-cholesterol levels associated with SI administration in cadmiuminduced oxidative stress in Wistar strain rats reported by Oyinloye
et al. (2016), and that of Sirato-Yasumoto et al. (2001) who reported
that sesame rich in lignans profoundly affects hepatic fatty acid oxida
tion and lowered serum triacylglycerol levels. The observed decrease in
TG concentration in the SI-treated rats compared with that of the un
treated rats serves as an indicator of the hypolipidemic potency of SI,
and thus has the potential of being preferred as sole usage or as an
adjuvant therapeutic remedy for hyperlipidemia-related disorders
compared with commonly employed hypolipidemic drugs.
Elevated phospholipid concentrations which may be indicative of
phospholipidosis was observed in all the organs and plasma of the un
treated hyperlipidemic rats compared with the baseline data, however
only to significant levels in the liver and heart of the rats as presented in
Fig. 2a. The ameliorative effect of SI in reducing the phospholipid levels
in the SI-administered rats comparable to the drug-treated rats was
demonstrated in all the studied tissues with the effect more evident in
the kidney, liver and heart of the rats with about 2–3-fold reduced
phospholipid levels. The mitigating effects of SI in assuaging the phos
pholipidosis induced by the high-fat diet fed to the rats demonstrate its
hypolipidemic potency and comparative effectiveness to commonly
employed hypolipidemic remedies.
The HDL-cholesterol (HDL-C) concentrations in the organs and
plasma of the investigated rats are presented in Fig. 2b. The HDL-C
concentrations of the investigated rat organs except that of the plasma
in the untreated hyperlipidemic rats were significantly reduced (p <
0.05) compared with the baseline data, with about 73-, 28-, 44-, 34- and
2-fold respective reduced HDL-C concentrations in the kidney, liver,
heart brain and plasma of the untreated rats. However, with the
administration of SI in the experimental group rats, HDL-C concentra
tions were significantly improved in most of the investigated rat organs
with about 31-, 7-, 19-, 15- and 2-fold improvement in the kidney, liver,
heart, brain and plasma of the rats. Compared with the other investi
gated tissues in the study, the HDL-C concentrations in the rats’ plasma

The activity of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA)
reductase was determined following the schemes of Rao and Ram
akrishnan (1975) in which the ratio of the concentrations of HMG-CoA
and mevalonate in the rat plasma serves as an index of the activity of
HMG-CoA reductase required to convert HMG-CoA to mevalonate in the
presence of NADPH indirectly indicating the inhibition or activation of
cholesterogenesis. Increase in the ratio implies decrease in the activity of
the enzyme/inhibition of cholesterogenesis in the plasma and vice versa.
2.7. Statistical analyses
Results were expressed as mean ± SEM and analyzed using Analysis
of Variance (ANOVA) followed by Tukey’s test for pairwise comparison
between the various groups of animals to determine the influence of
treatments, and p < 0.05 was considered significant. SPSS version 20
was employed in the analysis of the obtained data.
3. Results
3.1. Sesamum indicum administration led to weight changes in
hyperlipidemic rats
The weight changes of the animals over the four-week duration of
treatment is presented in Table 2. The weights of the animals in the
Sesamum indicum (SI) and the drug-treated groups steadily increased
from 62.40 ± 3.71 g to 180.00 ± 14.14 g and 63.00 ± 5.39 g to 136.00
± 29.00 g respectively, while in the untreated group, the weights
increased rapidly from 63.00 ± 3.74 g to 234.00 ± 31.30 g. The pro
gressive increase in weight of the rats in all the groups through the
course of the study could be attributed to the high-fat diet the rats were
fed with, as there was a significant increase in the weights of all the rats
obtained in the 4th week of treatment compared with that of the base
line weights. Notably, a significant reduction in the weights of animals
in the experimental group (SI-treated animals) compared with that of
the negative control group (untreated animals) was observed as shown
in Table 2. This might be indicative of the hypolipidemic potency of SI as
its administration on the hyperlipidemic rats in this study had a signif
icant weight-reducing effect comparable to that obtained with atorvas
tatin treatment. The weight-reducing effect of SI on hyperlipidemic rats
observed in this study is consistent with the reports of Nandakumaran
et al. (2015) and Aslam et al. (2020) who observed a substantial
decrease in rats’ body weight after 30- and 42-days continuous admin
istration of SI oil.
Table 2
The mean weights and weight changes of animals fed high fat diet (0–4 week)
and treated over a 4-week period (4–8 week) with Sesamum indicum or
atorvastatin.
Groups

*Baseline
weight (g)

2nd week
weights
(g)

4th week
weights
(g)

6th week
weights
(g)

8th week
Weights
(g)

Untreated

63.00 ±
3.74a

62.60 ±
7.53a
63.00 ±
5.39a
62.40 ±
3.71a

110.42 ±
5.45a
108.28 ±
4.81a
109.21 ±
6.50a

138.00 ±
30.33a,b
92.00 ±
08.37a
107.00 ±
21.09a,b

234.00 ±
31.30b,c
136.00 ±
29.00a,b
180.00 ±
14.14a,c

Drugtreated
Sesamum
indicumtreated

Values are expressed as mean ± SEM, n = 5. Values with different superscript
letters down the columns and across rows are significantly different at p < 0.05.
*Animals in the groups were randomly selected after 2 weeks of acclimatization
on commercial rat chow and water, sacrificed and weight at week 0 noted.
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Fig. 1. Total cholesterol and triglyceride concentrations in rat organs and plasma. (a) Total cholesterol concentration in the kidney, liver, heart, brain and plasma of
Sesamum indicum-treated, drug treated and untreated rats. (b) Total triglyceride concentration in the kidney, liver, heart, brain and plasma of Sesamum indicumtreated, drug treated and untreated rats. All values are expressed as mean ± SEM, n = 5. Bars belonging to the same assayed tissue with different letters are
significantly different at p < 0.05.

Fig. 2. Phospholipid and HDL-cholesterol concentrations in rat organs and plasma. (a) Phospholipid concentration in the kidney, liver, heart, brain and plasma of
Sesamum indicum-treated, drug treated and untreated rats. (b) HDL-cholesterol concentration in the kidney, liver, heart, brain and plasma of Sesamum indicum-treated,
drug treated and untreated rats. All values are expressed as mean ± SEM, n = 5. Bars belonging to the same assayed tissue with different letters are significantly
different at p < 0.05.

Fig. 3. HDL-triglyceride and HDL-phospholipid concentrations in rat organs and plasma. (a) HDL-triglyceride concentration in the kidney, liver, heart, brain and
plasma of Sesamum indicum-treated, drug treated and untreated rats. (b) HDL-phospholipid concentration in the kidney, liver, heart, brain and plasma of Sesamum
indicum-treated, drug treated and untreated rats. All values are expressed as mean ± SEM, n = 5. Bars belonging to the same assayed tissue with different letters are
significantly different at p < 0.05.
4
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were quite very low. The enhanced HDL-C concentrations in the SItreated rats across all tissues examined in the study compared with
that from the tissues of untreated rats is implicative of the hypolipidemic
potency of SI as HDL-C is inversely correlated with hyperlipidemiaassociated morbidities. These observations are consistent with that of
Oyinloye et al. (2016) who reported reduced serum TC, TG and LDLcholesterol levels and enhanced HDL-C levels as a result of the admin
istration of 200 or 400 mg/kg body weight SI to rats with cadmiuminduced oxidative stress.
Fig. 3a illustrates the concentration of high-density lipoprotein-tri
glyceride (HDL-TG) in rat organs and plasma. As observed in the study
outcomes, there was a significant reduction in the HDL-TG concentra
tion in the tissues of the untreated rats compared with the baseline
measurements, while a significant increase was observed in the HDL-TG
concentrations across all the investigated rat tissues except that of the
plasma in both the drug-treated rats and SI-treated rats compared with
that of the untreated rats. The increased HDL-TG concentrations
observed in both the drug-treated rats and SI-treated rats’ tissues may
have negative health implications as previous studies identified HDL-TG
as a cardiovascular risk marker, as its high concentration is associated
with hypertriglyceridemia and several cardiovascular diseases due to its
altered structure and function, opposite to that of HDL-C (Girona et al.,
2019; Ito & Ito, 2020). A possible underlying reason for the elevated
HDL-TG concentration in both the plasma and the investigated rat or
gans in the SI-treated rats might be the high saturated fatty acid content
of sesame seeds which could have influenced the HDL-TG levels in the
SI-supplemented rats as saturated fatty acids are known substrates for
TG synthesis.
The concentrations of high-density lipoprotein-phospholipids (HDLPL) is shown in Fig. 3b. The significantly reduced HDL-PL concentrations
observed across all the investigated tissues of the untreated rats
compared with the baseline values was improved by the administration
of SI and atorvastatin in the experimental and drug-treated rats,
respectively. As depicted in Fig. 3b, the HDL-PL concentrations were
about 35-, 11-, 41-, 31- and 2-fold lower than the baseline data in the
kidney, liver, heart, brain and plasma of the untreated rats. However,
treatment with SI led to about 10-, 4- and 20-fold respective improve
ments in the HDL-PL concentrations in the kidney, liver and brain tis
sues, while only about 2-fold improvement was observed in the heart
and plasma of the rats belonging to the experimental group, compared
with those of the untreated rats. Previously, a direct correlation between
increased HDL-PL concentrations and reduced incidence of cardiovas
cular diseases as it facilitates regression of atherosclerotic plaques by
promoting the efflux of cholesterol from cells had been reported
(Fournier et al., 2001). The elevated HDL-PL concentrations observed
across the investigated tissues of the SI-treated rats is indicative of the
hypolipidemic potential of sesame seed and its suitability as a thera
peutic remedy for hyperlipidemic-related morbidities.
To ascertain the respective impacts of SI and atorvastatin on HMGCoA reductase, the rate-limiting enzyme of the cholesterol biosyn
thetic pathway, catalyzing the reduction of HMG-CoA to mevalonate,
the ratio of HMG-CoA to mevalonate which serves as the index of the
activity of HMG-CoA reductase was determined in the plasma of the rats
from both the treated and untreated groups. As evident from Fig. 4, there
was a significant increase in the HMG-CoA/mevalonate ratio in both the
SI-treated rats as well as the drug-treated rats compared with that of the
untreated rats, implying the inhibition of HMG-CoA reductase activity in
the treated rats. Moreover, previous studies had identified the inhibition
of NADPH-dependent HMG-CoA reductase as the principal strategy for
lowering blood lipid levels (Rai et al., 2009; Tuansulong et al., 2011).
The observed inhibition of HMG-CoA reductase in the SI-treated rats
which might be responsible for the reduced concentration of the major
lipids (cholesterol, triglycerides and phospholipids) establishes the
hypolipidemic potential of SI and its suitability as dietary therapy in the
treatment of atherosclerosis and other hyperlipidemia-related disorders.

Fig. 4. HMG-CoA/mevalonate ratio as an index for the activity of HMG-CoA
reductase in the plasma of Sesamum indicum-treated, drug-treated and un
treated rats with the baseline measurements. All values are expressed as mean
± SEM, n = 5. Bars with different letters are significantly different at p < 0.05.

3.3. Discussion
Generally, a high-fat diet is a risk factor leading to whole body fat
accumulation and distribution, particularly the accumulation of visceral
adipose tissue. Although many synthetic hypolipidemic drugs exist and
are the first choice in lowering blood cholesterol levels in patients with
or at risk of cardiovascular diseases due to their health benefits, however
their inherent adverse side-effects such as hepatotoxicity in various
clinical settings calls for natural remedies with minimal or no detri
mental secondary effects (Bjornsson, 2017; Kumar et al., 2011). The SI
seed supplementation at 50% used in this study was chosen since earlier
results reported by Asgary et al (2013) indicated that 10 % SI supple
mentation did not yield any significant alteration in lipid profile pa
rameters. The observed ameliorative effect of the SI seeds on HFDinduced abnormal lipid profile of experimental rats in this study made
us conclude that SI seeds are suitable as sole or adjuvant curative remedy
for hyperlipidemia and associated complications, in place of the
commonly administered synthetic hypolipidemic drugs. Statins have
been employed as choice drug in the management of hyperlipidemia and
other pathologies associated with elevated lipid levels. The atorvastatin
dose of 5 mg/kg/day employed in this study was chosen in line with the
previous work of Seo et al. (2020). The observed increase in weight of
the rats (Table 2) over the duration of the study serves as an indicator of
the hyperlipidemic effect of the compounded high fat diet on the study
animals. The fall in body weight gain in the SI-treated rats suggests that
SI may have exerted inhibitory effects on gastrointestinal tract motility
consequentially resulting in the decline in the quantity of food intake
and ultimately reduced body weight. This observation is consistent with
previous reports in which a significant reduction in feed intake occurred
as a result of inclusion of sesame oil in the diet of animal models, with
concomitant reduction in weight (Aslam et al., 2020; Biswas et al.,
2010).
Lipoproteins mainly function in maintaining lipid homeostasis by
transporting lipids (including cholesterol and TGs) through the vascular
and extravascular fluids in the body. Generally, increased levels of
HDL–C and a concomitant reduction in TG, TC, phospholipids and LDLcholesterol levels are correlated with reduced vulnerability to athero
sclerosis and other degenerative cardiovascular diseases (Reena et al.,
2011; Shimada et al., 2004). As observed in our findings, the adminis
tration of SI significantly reduced (p < 0.05) the elevated TC, TG and
phospholipid concentrations observed in the tissues of the untreated
rats, while elevating the HDL-C concentrations, thereby demonstrating
the potency of SI in reversing the dyslipidemia induced by the hyper
lipidemic diet predisposing the untreated rats to cardiovascular diseases
and co-morbidities. These observations are congruent with the findings
5
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of Asgary et al (2013) in which decreased plasma concentration of lipids
in rabbits fed with 5% SI oil-supplemented diet was reported. A possible
explanation for the hypolipidemic effect of SI may be attributed to the
seed’s rich content in monounsaturated and polyunsaturated fatty acids,
or the presence of bioactive substances possessing HMG-CoA reductase
inhibitory properties. Moreover, as reported previously, sesame lignans
reduce serum and liver cholesterol concentrations by inhibiting the in
testinal absorption of cholesterol and reducing the activity of acyl-CoA
cholesterol acyl transferase and 3-hydroxy-3-methyl glutaryl CoA
reductase (Afroz et al., 2019; Andargie et al., 2021; Kumar & Singh,
2015; Wu et al., 2019). Furthermore, the observed hypotriglyceridemic
effect of SI seed supplementation could be attributed to the presence of
sesamol, one of the bioactive constituents that has been previously re
ported to inhibit the intestinal absorption of triglycerides and promote
cholesterol efflux from the blood when administered at a dosage of 50
mg/kg and 100 mg/kg on hyperlipidemia model mice, thus attenuating
hypercholesterolemia and associated disorders (Kumar et al., 2013;
Sirato-Yasumoto et al., 2001). Another plausible mechanism for the
observed lipid-lowering effect of SI may be due to the suppression of the
expression of the lipogenesis-related gene - sterol regulatory elementbinding protein-1 (SREBP1) (a key transcription factor involved in the
biosynthesis of cholesterol and fatty acids) at the mRNA level or by the
upregulation of the low density lipoprotein (LDL) receptor and the
expression of cholesterol-7α-hydroxylase gene, the rate-limiting enzyme
in the conversion of cholesterol to bile acids for excretion. Furthermore,
the up-regulation of the expression of lipolysis-associated peroxisome
proliferator-activated receptor-α (PPAR-α) and cluster of differentiation
36 (CD36), energy expenditure-associated uncoupling protein 2 (UCP2)
and carnitinepalmitoyltransferase-1 (CPT1) at the mRNA level, and
increased fatty acid oxidation via adenosine monophosphate-activated
protein kinase (AMPK) activation in adipose tissues might contribute
to facilitating the lipid-lowering effect of SI administration in the
hyperlipidemic rats (Yuan et al., 2016). In a previous report, the sup
plementation of sesame seeds at 200 g/kg in rats’ experimental diet was
reported to increase the activity of both hepatic mitochondrial and
peroxisomal fatty acid oxidation enzymes such as acyl-CoA oxidase,
carnitine palmitoyltransferase, 3-hydroxyacyl-CoA dehydrogenase, and
3-ketoacyl-CoA thiolase, while enzymes involved in fatty acid synthesis
including fatty acid synthase, glucose-6-phosphate dehydrogenase, ATPcitrate lyase, and pyruvate kinase were down-regulated (Sirato-Yasu
moto et al., 2001). Moreover, the change in the rate of fatty acid syn
thesis and oxidation in the liver might be responsible for alterations in
lipid concentrations in the plasma and extra-hepatic tissues as they
depend on the liver for their lipid supply (Nwozo et al., 2017; Banjoko
et al., 2012). The mechanisms by which SI administration modulates the
expression and activity of these enzymes deserves attention in future
studies.
Previous studies have shown that HDL functionality is a better
determinant of HDL-mediated cardiovascular protection than HDLcholesterol. In contrast to HDL-cholesterol, HDL–TG has been reported
to be directly associated with metabolism and arteriosclerotic vascular
alterations and serves as a biomarker for metabolic and cardiovascular
risk (Girona et al., 2019; Ito & Ito, 2020; Srivastava, 2018). In our study,
we observed an unexpected significant increase (p < 0.05) in the HDLTG concentration in the tissues of the SI-administered rats and drugtreated rats compared with the untreated hyperlipidemic rats. In
actual fact, the obtained baseline data shows high HDL-TG levels. As
high HDL-TG levels are correlated with predisposition to arterial plaques
due to their cholesterol-rich content, the enhanced HDL-TG concentra
tions observed both in the SI-treated rats as well as the drug-treated rats
contradicts their suitability as hypolipidemic therapies. The underlying
reason for this observed trend demands further investigations.
HDL-PL is a very important parameter in regulating the efficiency of
cells in stimulating cholesterol efflux as enrichment of lipoproteins with
phospholipids has been found to significantly enhance cellular choles
terol efflux since they regulate the size and composition of plasma HDL

levels (Fournier et al., 2001). Moreover, lower HDL-cholesterol and
particularly HDL-phospholipids but elevated HDL-triglycerides have
been correlated with incidence of coronary artery disease (Fournier
et al., 2001; Piperi et al., 2004; Srivastava, 2018). As noted in our study,
dietary supplementation with Sesamum indicum in the experimental rats
as well as the treatment of the rats in the drug-treatment group with
atorvastatin markedly enhanced the HDL-phospholipid content in the
investigated tissues, thus confirming the hypolipidemic potential of SI
and its eligibility as an adjuvant lipid-lowering therapeutic agent.
The Inhibition of NADPH-dependent HMG-CoA reductase catalyzing
the reduction of HMG-CoA to mevalonate, the significant rate-limiting
regulatory step in cholesterol biosynthetic pathway has been identi
fied as the main strategy utilized by commonly employed drugs for
lowering blood cholesterol levels or reducing the risk of cardiovascular
diseases (Mukherjee et al., 2016; Rai et al., 2009; Tuansulong et al.,
2011). In our study, we observed a significant increase in the HMG-CoA/
mevalonate ratio in the plasma of both SI-treated rats as well as that of
the drug-treated rats compared with that of the untreated hyper
lipidemic rats, implying the inhibition of HMG-CoA reductase activity as
a result of the supplementation of SI in the diet of the experimental rats,
thus reducing the amount of cholesterol synthesized in the tissues.
Consistent with this observation is the reduced TC content of the liver
and extra-hepatic tissues of both the SI-treated rats and the atorvastatintreated rats observed in this study. This finding agrees with the report of
Tuansulong et al. (2011) in which the hypocholesterolemic effect of
morelloflavone derived from Garcinia dulcis in experimental animals was
attributed to its inhibition of HMG-CoA reductase leading to a decrease
in de novo cholesterol synthesis. Moreover, as reported previously, ses
amin, one of the most important lignan components of sesame seeds
exhibited hypocholesterolemic effect via the downregulation of HMGCoA reductase activity (Hirose et al., 1991).
It is worthy to note a number of limitations of this study. In the first
instance, we did not investigate the parameters related to oxidative
stress and inflammation. Secondly, the histopathological studies of the
organs were also not reported. We acknowledge further studies in these
areas to demonstrate whether the induced hyperlipidemia is accompa
nied by inflammation and oxidative stress; and the possible ameliorative
effects of the seed on these parameters compared with the use of
atorvastatin.
3.4. Conclusion
In summary, in the present study we show that dietary supplemen
tation with SI could favorably modulate dyslipidemia and atheroge
nicity of lipid profiles with its associated complications in rats fed high
fat diet. The mechanism by which SI exhibits its hypolipidemic effect is
attributed to the inhibition of the NADPH-dependent HMG-CoA reduc
tase, the rate-limiting enzyme in cholesterol biosynthetic pathway,
mediated by its constituent phytochemicals. The hypolipidemic modu
latory effects of Sesamum indicum observed in this study potentiates its
suitability as adjuvant therapeutic agent for treating hyperlipidemia and
associated morbidities, while obviating the detrimental hepatotoxic
side–effects associated with the use of commonly employed blood lipidlowering drugs.
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